Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-15 5:31 pm Purchase | 2026-04-14 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,739,024 19.900% | 184,382 (+1.47%) | Filing History |
| 2026-04-10 6:25 pm Purchase | 2026-04-09 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,554,642 19.900% | 154,936 (+1.25%) | Filing History |
| 2026-04-08 6:45 pm Purchase | 2026-04-06 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,399,706 19.900% | 212,182 (+1.74%) | Filing History |
| 2026-04-01 5:29 pm Purchase | 2026-03-30 | 13G | VOR BIOPHARMA INC VOR | TCG Crossover GP II, LLC | 5,673,078 10.500% | 5,673,078 (New Position) | Filing History |
| 2026-04-01 5:09 pm Purchase | 2026-03-30 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,187,524 19.900% | 3,164,456 (+35.07%) | Filing History |
| 2026-03-16 4:15 pm Purchase | 2026-03-12 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 9,023,068 19.900% | 3,611,547 (+66.74%) | Filing History |
| 2026-02-17 6:59 pm Purchase | 2025-12-31 | 13G | VOR BIOPHARMA INC VOR | Verve Capital Limited | 4,297,464 9.900% | 3,536,765 (+464.94%) | Filing History |
| 2026-02-17 6:22 pm Purchase | 2025-12-31 | 13G | VOR BIOPHARMA INC VOR | Venrock Healthcare Capital Partners III L.P. | 2,216,075 9.900% | 1,455,376 (+191.32%) | Filing History |
| 2026-02-17 4:13 pm Purchase | 2025-12-31 | 13G | VOR BIOPHARMA INC VOR | GREAT POINT PARTNERS LLC | 1,370,107 3.300% | 135,621 (+10.99%) | Filing History |
| 2026-02-17 4:02 pm Unchanged | 2025-12-31 | 13G | VOR BIOPHARMA INC VOR | Paradigm Biocapital Advisors LP | 1,750,000 4.500% | 0 (Unchanged) | Filing History |
| 2026-02-13 7:47 pm Purchase | 2025-12-31 | 13G | VOR BIOPHARMA INC VOR | Qiming Venture Partners VIII-HC L.P. | 1,089,767 2.800% | 593,495 (+119.59%) | Filing History |
| 2026-02-05 1:40 pm Purchase | 2025-12-31 | 13G | VOR BIOPHARMA INC VOR | FMR LLC | 2,526,170 6.500% | 1,737,723 (+220.40%) | Filing History |
| 2025-12-23 4:05 pm Purchase | 2025-12-18 | 13D | VOR BIOPHARMA INC VOR | ForGrowth III PA B.V. | 10,237,714 9.990% | 3,237,714 (+46.25%) | Filing History |
| 2025-12-19 4:40 pm Purchase | 2025-12-18 | 13G | VOR BIOPHARMA INC VOR | Frazier Life Sciences Public Fund, L.P. | 2,258,001 5.800% | 2,258,001 (New Position) | Filing History |
| 2025-12-18 6:31 pm Purchase | 2025-12-18 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 5,411,521 14.000% | 3,066,244 (+130.74%) | Filing History |
| 2025-12-17 4:00 pm Purchase | 2025-12-10 | 13G | VOR BIOPHARMA INC VOR | GREAT POINT PARTNERS LLC | 1,234,486 5.630% | 1,234,486 (New Position) | Filing History |
| 2025-11-18 4:30 pm Purchase | 2025-11-11 | 13G | VOR BIOPHARMA INC VOR | Paradigm Biocapital Advisors LP | 1,750,000 8.600% | 1,750,000 (New Position) | Filing History |
| 2025-11-14 6:13 pm Purchase | 2025-11-12 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 2,345,277 9.900% | 1,534,606 (+189.30%) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | VOR BIOPHARMA INC VOR | FMR LLC | 788,447 11.500% | 683,813 (+653.53%) | Filing History |
| 2025-11-05 4:14 pm Purchase | 2025-09-18 | 13G | VOR BIOPHARMA INC VOR | Qiming Venture Partners VIII-HC L.P. | 496,272 5.440% | 496,272 (New Position) | Filing History |